Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Dyslipidemia

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 39 articles: HTML format

Single Articles

April 2020
1. RAY KK, Wright RS, Kallend D, Koenig W, et al
   Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
   N Engl J Med. 2020;382:1507-1519.
   PubMed     Abstract available
   
   
   January 2020
2. LUIRINK IK, Kusters DM, Hutten BA
   Statins for Familial Hypercholesterolemia from Childhood. Reply.
   N Engl J Med. 2020;382:488-489.
   PubMed    
   
   
   
3. MURATA Y, Kami M
   Statins for Familial Hypercholesterolemia from Childhood.
   N Engl J Med. 2020;382:488.
   PubMed    
   
   
   
4. BIJL D, Hama R
   Statins for Familial Hypercholesterolemia from Childhood.
   N Engl J Med. 2020;382:487-488.
   PubMed    
   
   
   December 2019
5. WITZTUM JL, Geary RS, O'Dea L
   Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia. Reply.
   N Engl J Med. 2019;381:2584.
   PubMed    
   
   
   
6. KHETARPAL SA, Wang M, Khera AV
   Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia.
   N Engl J Med. 2019;381:2582-2584.
   PubMed    
   
   
   October 2019
7. MICHOS ED, McEvoy JW, Blumenthal RS
   Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.
   N Engl J Med. 2019;381:1557-1567.
   PubMed    
   
   
   
8. LUIRINK IK, Wiegman A, Kusters DM, Hof MH, et al
   20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
   N Engl J Med. 2019;381:1547-1556.
   PubMed     Abstract available
   
   
   September 2019
9. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
   Polypill for Cardiovascular Disease Prevention in an Underserved Population.
   N Engl J Med. 2019;381:1114-1123.
   PubMed     Abstract available
   
   
   August 2019
10. WITZTUM JL, Gaudet D, Freedman SD, Alexander VJ, et al
    Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
    N Engl J Med. 2019;381:531-542.
    PubMed     Abstract available
    
    
    April 2019
11. BHATT DL, Steg PG, Miller M
    Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.
    N Engl J Med. 2019;380:1678.
    PubMed    
    
    
    
12. BORGHI C, Fogacci F, Cicero AFG
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1678.
    PubMed    
    
    
    
13. CHAN LN
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1677.
    PubMed    
    
    
    March 2019
14. FERENCE BA, Ray KK, Catapano AL, Ference TB, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2019;380:1033-1042.
    PubMed     Abstract available
    
    
    
15. RAY KK, Bays HE, Catapano AL, Lalwani ND, et al
    Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
    N Engl J Med. 2019;380:1022-1032.
    PubMed     Abstract available
    
    
    January 2019
16. KASTELEIN JJP, Stroes ESG
    FISHing for the Miracle of Eicosapentaenoic Acid.
    N Engl J Med. 2019;380:89-90.
    PubMed    
    
    
    November 2018
17. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812792.
    PubMed     Abstract available
    
    
    
18. SCHWARTZ GG, Steg PG, Szarek M, Bhatt DL, et al
    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
    N Engl J Med. 2018 Nov 7. doi: 10.1056/NEJMoa1801174.
    PubMed     Abstract available
    
    
    August 2018
19. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Abstract available
    
    
    May 2018
20. KOEHLER VF, Parhofer KG
    Xanthoma Striatum Palmare.
    N Engl J Med. 2018;378:e26.
    PubMed    
    
    
    November 2017
21. CALABRO P, Gragnano F, Pirro M
    Cognitive Function in a Randomized Trial of Evolocumab.
    N Engl J Med. 2017;377:1996-7.
    PubMed    
    
    
    
22. GIUGLIANO RP, Sabatine MS, Ott BR
    Cognitive Function in a Randomized Trial of Evolocumab.
    N Engl J Med. 2017;377:1997.
    PubMed    
    
    
    September 2017
23. ADAMS TD, Davidson LE, Litwin SE, Kim J, et al
    Weight and Metabolic Outcomes 12 Years after Gastric Bypass.
    N Engl J Med. 2017;377:1143-1155.
    PubMed     Abstract available
    
    
    August 2017
24. POONIA A, Giridhara P
    Xanthomas in Familial Hypercholesterolemia.
    N Engl J Med. 2017;377:e7.
    PubMed    
    
    
    July 2017
25. GAUDET D, Gipe DA, Pordy R, Ahmad Z, et al
    ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2017;377:296-297.
    PubMed    
    
    
    April 2017
26. RIDKER PM, Tardif JC, Amarenco P, Duggan W, et al
    Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
    N Engl J Med. 2017;376:1517-1526.
    PubMed     Abstract available
    
    
    
27. BEIGNEUX AP, Miyashita K, Ploug M, Blom DJ, et al
    Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
    N Engl J Med. 2017 Apr 5. doi: 10.1056/NEJMoa1611930.
    PubMed     Abstract available
    
    
    March 2017
28. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
    Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
    PubMed     Abstract available
    
    
    
29. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    PubMed     Abstract available
    
    
    
30. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    PubMed     Abstract available
    
    
    February 2017
31. KHERA AV, Kathiresan S
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498-9.
    PubMed    
    
    
    
32. MARTIN AC, Watts GF
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498.
    PubMed    
    
    
    
33. KULLO IJ, Safarova MS
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498.
    PubMed    
    
    
    
34. HINGORANI AD, Futema M, Humphries S
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:499.
    PubMed    
    
    
    
35. 
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2017;376:498-500.
    PubMed    
    
    
    January 2017
36. SCHULMAN AR, Vaidya A, Tavakkoli A, Jajoo K, et al
    Making the Connection.
    N Engl J Med. 2017;376:e5.
    PubMed    
    
    
    October 2016
37. WALD DS, Bestwick JP, Morris JK, Whyte K, et al
    Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    N Engl J Med. 2016;375:1628-1637.
    PubMed     Abstract available
    
    
    
38. MCCRINDLE BW, Gidding SS
    What Should Be the Screening Strategy for Familial Hypercholesterolemia?
    N Engl J Med. 2016;375:1685-1686.
    PubMed    
    
    
    September 2016
39. LAMPSON BL, Gray SW, Cibas ES, Levy BD, et al
    CLINICAL PROBLEM-SOLVING. Tip of the Tongue.
    N Engl J Med. 2016;375:880-6.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: